Results 171 to 180 of about 1,665,622 (222)

Mapping Lysosomal Storage Disorders with Neurological Features by Cellular Pathways: Towards Precision Medicine. [PDF]

open access: yesCurr Issues Mol Biol
Makridou A   +6 more
europepmc   +1 more source

Therapeutic potential of the sphingosine kinase 2 inhibitor opaganib. [PDF]

open access: yesPharm Sci Adv
Huang F   +6 more
europepmc   +1 more source

Proteomic analysis of mitochondria-ER contacts reveals key proteins involved in metabolic regulation in hepatocytes. [PDF]

open access: yesCell Commun Signal
Yang H   +9 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Activator proteins and topology of lysosomal sphingolipid catabolism

Lipids and Lipid Metabolism, 1992
The lysosomal degradation of several sphingolipids by acid hydrolases is dependent on small non-enzymic cofactors, called sphingolipid activator proteins some of which have been identified as sphingolipid binding proteins. This review summarizes the information available on the structure, function, biosynthesis, gene organization and pathobiochemistry ...
Konrad Sandhoff, W Fürst
exaly   +3 more sources

Stimulation of lysosomal sphingomyelin degradation by sphingolipid activator proteins

Chemistry and Physics of Lipids, 1999
Lysosomal breakdown of glycosphingolipids with short hydrophilic carbohydrate headgroups is achieved by the simultaneous action of specific hydrolases and sphingolipid activator proteins (SAPs). Activator proteins are considered to facilitate the enzyme/substrate interaction between water-soluble enzymes and membrane-bound substrates.
Konrad Sandhoff   +2 more
exaly   +3 more sources

Home - About - Disclaimer - Privacy